This Vet Times Extra Podcast sees Paul Imrie speaking with Andrew Biggs of The Vale Veterinary Group and Kath Aplin from Boehringer Ingelheim Animal Health about targeted mastitis therapy. The podcast is sponsored by Boehringer Ingelheim, who bring us Ubropen, Ubrolexin and Metacam. We’re going to talk about how mastitis treatment has changed over the years, what affects cure rates and we’ll discuss the pros and cons of a targeted mastitis therapy approach using on-farm culture. Treating cows with mastitis is one of the most common reasons for using antibiotics on dairy farms, so it’s a highly relevant topic for any vet involved with dairy work. ______________________ 𝗔𝗡𝗗𝗥𝗘𝗪 𝗕𝗜𝗚𝗚𝗦, 𝗕𝗩𝗦𝗰, 𝗙𝗥𝗖𝗩𝗦 Andy is a director at The Vale Veterinary Group in Tiverton, Devon. He runs The Vale Veterinary Laboratory processing mainly milk and bedding samples and has authored and co-authored many scientific papers and articles and written a book Mastitis in Cattle. He is a fellow of the RCVS and a past-president of WCVA and BCVA and was awarded the Dalrymple-Champneys Cup and Medal from the BVA in 2015. He lectures widely around the world to farmers, students and vets and is the sole tutor for the masters mastitis module at Massey Vet School in New Zealand. ______________________ 𝗞𝗔𝗧𝗛 𝗔𝗣𝗟𝗜𝗡 𝗕𝗩𝗦𝗰, 𝗖𝗲𝗿𝘁𝗖𝗛𝗣, 𝗠𝗥𝗖𝗩𝗦 Kath is a ruminant veterinary advisor for Boehringer Ingelheim Animal Health, providing technical support for the ruminant range of medicines in Scotland and the north of England. Before joining Boehringer, Kath worked in cattle practice for 20 years, in Somerset, New Zealand and Cumbria. ______________________ 𝗦𝗣𝗢𝗡𝗦𝗢𝗥𝗘𝗗 This podcast is sponsored by the makers of Ubropen, Ubrolexin and Metacam, Boehringer Ingelheim. Ubropen® 600mg intramammary suspension for lactating cows contains benzylpenicillin procaine monohydrate. Ubrolexin® contains cefalexin and kanamycin. Metacam® 20mg/ml solution for injection for cattle, pigs and horses contains meloxicam. UK: POM-V IE: POM. Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. UK Tel: 01344 746960 (sales) or 01344 746957 (technical), IE Tel: 01 291 3985 (all queries). Email: [email protected] Ubropen®, Ubrolexin® and Metacam® are registered trademarks of Boehringer Ingelheim Vetmedica GmbH, used under licence. ©2023 Boehringer Ingelheim Animal Health UK Ltd. All rights reserved. Date of preparation: April 2023. UI-BOV-0045-2023. Use Medicines Responsibly.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related